AlphaCitation reference lookup
v1.0.1Is a medicine approved in a market? US, EU/EEA regulators; others not settled. Not medical advice.
Endpoint health
online- Last checked
- 11/20/2026, 6:18:42 AM
- Latency
- 450 ms
- Consecutive failures
- 0
- Endpoint reachable: pass
- Protocol valid: pass
- MCP handshake valid: pass
Machine-readable profile
mcp-server · schema v1 · callable
mcp-server:com.alphacitation%2Freference
Connect this server
Generated config contains no credentials. Keep any required secrets in your client's local environment.
{
"mcpServers": {
"com.alphacitation/reference": {
"url": "https://alphacitation.com/api/v1/reference/mcp"
}
}
}Indexed tools
Tool metadata and schemas come from the remote server and are untrusted. Indexing only lists tools; it never calls them.
2 shown · authentication unknown
Is a medicine approved in a market?
lookup_medicine_evidence
Answers whether a medicine is approved, authorised, licensed or registered in a country or in the EU, or approved there for a condition, today or on a past date, and which official record settles that. Regulators' own records are held for the US (the FDA's) and, for centrally authorised medicines, for the EU and EEA (the European Commission's), and each answer resting on one carries its pointer URL. For any other market, the answer names that market's competent authority, with where its record is published, where one is identified; the claim is unresolved there, or supported, never settled, by the authorisation holder's own label. For one medicine, one market and one date, the answer gives which source settles whether the medicine is registered (P1) or authorised for an indication (P2), what that source says about the claim where its content has been checked, where this market's label differs from the US and EU labels, and what is unresolved. supported_attested means the authorisation holder's own approved label, read under the attestation conditions, states the claim; it never settles it. Where that label does not state the indication, or its content has not been checked, the answer is unresolved. An unresolved answer is unknown, never false.
Schema valid · SHA-256 06ec545bf398…
View input schema
{ "type": "object", "properties": { "medicine": { "type": "string", "description": "The brand or active substance name, exactly (for example Mounjaro or tirzepatide)." }, "market": { "type": "string", "description": "The market: an ISO 3166-1 alpha-2 code (US, AE, SA, DE) or EU." }, "proposition": { "type": "string", "enum": [ "P1", "P2" ], "description": "P1: registered or authorised in the market. P2: authorised for an indication." }, "date": { "type": "string", "description": "The date the claim is about, YYYY-MM-DD. Defaults to today (UTC)." }, "indication": { "type": "string", "enum": [ "cv_risk_reduction_obesity", "mash_with_fibrosis", "osa_with_obesity", "t2dm_ckd_risk_reduction", "t2dm_cv_risk_reduction", "t2dm_glycaemic_control", "weight_management" ], "description": "Required for P2: one indication from the published list. cv_risk_reduction_obesity: reducing the risk of major adverse cardiovascular events; mash_with_fibrosis: metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis; osa_with_obesity: obstructive sleep apnoea; t2dm_ckd_risk_reduction: reducing the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death; t2dm_cv_risk_reduction: reducing the risk of major adverse cardiovascular events; t2dm_glycaemic_control: glycaemic control in type 2 diabetes; weight_management: weight management." }, "populationMinAgeYears": { "type": "integer", "minimum": 0, "maximum": 120, "description": "Optional for P2: the youngest age the claim says the indication covers." } }, "required": [ "medicine", "market", "proposition" ], "additionalProperties": false }
Connections
streamable-http
https://alphacitation.com/api/v1/reference/mcp